It has been reported that HSP70, glypican-3 (GPC3), glutamine synthetase (GS), CD31, α-smooth muscle actin and CD34 may serve as biomarkers for the differential diagnosis of HCC or WDHCC and DN or HGDN [8-13]. Here, GLUL is linked to hepatocellular carcinoma.